Ignite Creation Date:
2024-05-05 @ 4:42 PM
Last Modification Date:
2024-10-26 @ 9:23 AM
Study NCT ID:
NCT00294372
Status:
TERMINATED
Last Update Posted:
2013-11-14
First Post:
2006-02-20
Brief Title:
Phase II Study on the Antiviral Activity and Safety of BILR 355 BS in HIV-1 Infected NNRTI-treated Patients
Sponsor:
Boehringer Ingelheim
Organization:
Boehringer Ingelheim
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-02
Start Date Type:
None
Primary Completion Date:
2007-09
Primary Completion Date Type:
ACTUAL
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2006-02-20
First Submit QC Date:
February 20 2006
Study First Post Date:
2006-02-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-11-13
Last Update Post Date:
2013-11-14
Last Update Post Date Type:
ESTIMATED